Filing Details

Accession Number:
0001104659-21-044710
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-31 15:50:18
Reporting Period:
2021-03-29
Accepted Time:
2021-03-31 15:50:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1508381 Bionik Laboratories Corp. BNKL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1209225 Gerald Peter Malone C/O Bionik Laboratories Corp.
483 Bay Street, N105
Toronto A6 M5G 2C9
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2021-03-29 26,430 $0.00 26,430 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reporting person acquired the shares of common stock in lieu of cash payment for an aggregate of $70,833.41 in accrued and unpaid fees relating to reporting person's services as a director of the Issuer.